Our Rapid Tests

At OncoFirm Diagnostics, we are transforming the future of rapid cancer diagnostics through next-generation lateral flow assay (LFA) technology. Our proprietary rapid tests are designed for early detection of multiple cancers, leveraging newly identified antigens and highly specific cancer biomarkers linked to disease progression. By combining scientific innovation with user-friendly formats, we deliver accurate, fast, and accessible screening tools for healthcare providers worldwide.*